2002 Clinical Trials Law Safety 
Cannabis Law Report
JULY 9, 2021
The state of the law on psychedelic substances is in flux. Some of the most promising substances, and the law applicable to each, are outlined below: Psilocybin. As such, the use, sale, and possession of psilocybin in the United States is illegal under federal law. have also passed “Right to Try” laws.
Cannabis Law Report
JUNE 14, 2022
We will be joined by excellent speakers including Dr. Thomas Insel – Former Director of the US National Institute of Mental Health (2002 – 2015), Prof. The partnership will be officially launched at the virtual event: Preparing Europe for Novel Psychedelic-Assisted Therapies taking place on 23rd June, 14:00 – 16:00 CEST. David Nutt and Prof.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 10, 2021
The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Support for per-se laws was higher among those in states that legalized recreational marijuana and in states with per-se laws. Materials and methods. Study sample. never vs. at least once). (2)
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Before 2016, Australian law considered cannabis an illegal drug. Bonini et al. A recent study by Lintzeris et al.
Expert insights. Personalized for you.
105 
Let's personalize your content